Scientists from Immanuel Kant Baltic Federal University (Russia) have developed an innovative way of drug delivery using stem cells.

According to Gazeta.Ru, the scientists have examined in vitro effect of synthetic polymeric microcapsules on cell morphology, ultrastructure and biological activity of mesenchymal stem cells. As it turned out, it is possible to integrate microcapsules into these cells without damaging cellular integrity, preserving its ability to move. In addition, cytokine secretion remains weak when this method is used, which is important for preventing excessive inflammation.

The scientists plan to use the results obtained in regenerative medicine, as the new technology has a high differentiation potential, and is also able to reduce inflammation and have a beneficial effect on the immune system. In the future, mesenchymal stem cells can be used to deliver drugs to specific organs and tissues where pathological processes occur, for example, to treat cancer, stroke or other diseases.